Disruptions in perinatal outcomes across Manitoba, Canada: before and over 2 years of the COVID-19 pandemic - Top-Institutions - MDSpire

Disruptions in perinatal outcomes across Manitoba, Canada: before and over 2 years of the COVID-19 pandemic

  • By

  • Laila Aboulatta

  • Kaarina Kowalec

  • Lisa M Lix

  • Mina Tadrous

  • Joseph A Delaney

  • Christine Leong

  • Jamie Falk

  • Silvia Alessi-Severini

  • Christina Raimondi

  • Katherine Kearns

  • Lara Haidar

  • Payam Peymani

  • Qier Tan

  • Sherif Eltonsy

  • June 29, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    University of Manitoba
    University of Manitoba

    Winnipeg, Manitoba

    Key Differentiators

    • Obstetrics
    • Public Health

  • #2

    University of British Columbia
    University of British Columbia

    Vancouver, British Columbia

    Key Differentiators

    • Obstetrics
    • Reproductive Health

  • #3

    Children’s Hospital Los Angeles
    Children’s Hospital Los Angeles

    Los Angeles, California

    Key Differentiators

    • Pediatrics
    • Cardiology

  • #4

    Dutch hospitals
    Dutch hospitals

    Various, Netherlands

    Key Differentiators

    • Obstetrics
    • Critical Care

  • #5

    Canadian Institute for Health Information
    Canadian Institute for Health Information

    Ottawa, Ontario

    Key Differentiators

    • Health Information
    • Public Health

Original Source(s)

Disruptions in perinatal outcomes across Manitoba, Canada: before and over 2 years of the COVID-19 pandemic

  • by Laila Aboulatta, Kaarina Kowalec, Lisa M Lix, Mina Tadrous, Joseph A Delaney, Christine Leong, Jamie Falk, Silvia Alessi-Severini, Christina Raimondi, Katherine Kearns, Lara Haidar, Payam Peymani, Qier Tan, Sherif Eltonsy

  • June 29, 2026

Related Content

Breastfeeding practices and perspectives in the setting of maternal HIV in high-income countries since the shift in the United States national guidelines: a scoping review

Surveillance May Reduce CIN 2 Overtreatment

Risk-based management may reduce unnecessary excisions in selected patients with CIN 2.

Complement as a driver of immune–vascular heterogeneity across preeclampsia subtypes: toward a precision medicine framework